Skip to content
healthcare.dev

FARGELIN HEMORRHOIDAL

NDC 55614-610, Calamine, Petrolatum and Phenylephrine hydrochloride, ointment, from MADISON ONE ACME INC.

Product NDC
55614-610
Status
Listed
Labeler
MADISON ONE ACME INC
Dosage form
OINTMENT
Route
RECTAL, TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55614-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZINC OXIDE10.3 g/100g
  • FERRIC OXIDE RED.05 g/100g
  • PETROLATUM79.25 g/100g
  • PHENYLEPHRINE HYDROCHLORIDE.25 g/100g

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
55614-610-015561406100120 g in 1 TUBE, WITH APPLICATOR (55614-610-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55614-610 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55614-610 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55614-610. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.